This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Development of an Urticaria Control Test (UCT-D)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
K. Weller, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01610128
First received: May 30, 2012
Last updated: January 5, 2017
Last verified: January 2017
  Purpose
The aim of the project is to develop a patient reported outcome instrument to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.

Condition
Chronic Urticaria

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: UCT - Development of an Instrument to Assess Disease Control in Patients With Chronic Urticaria (Urticaria Control Test)

Resource links provided by NLM:


Further study details as provided by K. Weller, Charite University, Berlin, Germany:

Enrollment: 508
Study Start Date: October 2011
Study Completion Date: August 2013
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
chronic urticaria patients
all patients suffering from chronic types of urticaria (chronic spontaneous urticaria as well as chronic inducible forms such as cold contact urticaria)

  Eligibility

Ages Eligible for Study:   12 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients suffering from chronic forms of urticaria
Criteria

Inclusion Criteria:

all patients suffering from chronic forms of urticaria are eligible

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01610128

Locations
Germany
Universitätshautklinik Mainz
Mainz, Rheinland-Pfalz, Germany, 55131
Allergie-Centrum-Charite
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

Responsible Party: K. Weller, Principal Investigator, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01610128     History of Changes
Other Study ID Numbers: UCT-D
Study First Received: May 30, 2012
Last Updated: January 5, 2017

Keywords provided by K. Weller, Charite University, Berlin, Germany:
urticaria, patient reported outcome

Additional relevant MeSH terms:
Urticaria
Skin Diseases, Vascular
Skin Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on June 28, 2017